Profound Medical Corp.
PRN.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 583.24% | -15.91% | 91.59% | -- | -- |
| Total Other Revenue | 53.26% | 6.92% | 25.16% | 31.66% | 53.53% |
| Total Revenue | 86.76% | -0.99% | 82.14% | 84.42% | 63.89% |
| Cost of Revenue | 30.08% | -26.97% | 34.03% | 15.78% | 56.29% |
| Gross Profit | 119.85% | 13.86% | 113.97% | 155.21% | 68.68% |
| SG&A Expenses | 12.18% | 84.38% | 71.13% | 13.92% | 57.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.05% | 58.98% | 47.99% | 15.13% | 42.74% |
| Operating Income | 0.94% | -76.05% | -41.75% | 0.66% | -37.16% |
| Income Before Tax | 14.50% | -126.54% | -63.22% | 37.34% | -65.67% |
| Income Tax Expenses | -31.64% | 236.84% | 2.50% | -3.93% | 883.33% |
| Earnings from Continuing Operations | 14.82% | -126.84% | -62.85% | 38.43% | -68.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.82% | -126.84% | -62.85% | 38.43% | -68.31% |
| EBIT | 0.94% | -76.05% | -41.75% | 0.66% | -37.16% |
| EBITDA | 0.20% | -79.61% | -44.26% | 2.18% | -38.81% |
| EPS Basic | 30.57% | -84.46% | -31.73% | 48.94% | -45.97% |
| Normalized Basic EPS | 30.33% | -84.30% | -32.01% | 48.06% | -43.71% |
| EPS Diluted | 30.57% | -84.46% | -31.73% | 48.94% | -45.97% |
| Normalized Diluted EPS | 30.33% | -84.30% | -32.01% | 48.06% | -43.71% |
| Average Basic Shares Outstanding | 22.70% | 22.96% | 23.65% | 20.60% | 15.32% |
| Average Diluted Shares Outstanding | 22.70% | 22.96% | 23.65% | 20.60% | 15.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |